Assessing ChatGPT vs. evidence-based online responses for polycystic ovary syndrome self-management and education: an international cross-sectional blinded survey of healthcare professionals

• by Sandro Graca, Alexander Dallaway, Folashade Alloh, Harpal S. Randeva, Chris Kite, Ioannis Kyrou

• March 31, 2026

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

• by Kathryn Wighton

• April 1, 2026

• 2 min

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min

Integrating evidence-based lifestyle and adjunct therapies for long-term management of polycystic ovary syndrome: mechanistic insights and clinical implications

• by Prasanth Babu Nandagopal, Gopika Jayakrishnan, Anu Varghese Kaithamattathil, Venkatraman Manickam

• May 28, 2026